Celldex Therapeutics buy Guggenheim
Start price
20.07.26
/
50%
€30.96
Target price
20.07.27
€87.40
Performance (%)
-0.65%
Price
24.07.26
€30.68
Summary
This prediction is currently active. The BUY prediction by Guggenheim for Celldex Therapeutics is nearly unchanged. This prediction currently runs until 20.07.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Celldex Therapeutics | -0.65% |
| iShares Core DAX® | 0,85 % |
| iShares Nasdaq 100 | -0,99 % |
| iShares Nikkei 225® | -1,78 % |
| iShares S&P 500 | 0,06 % |
Comments by Guggenheim for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its price target raised by Guggenheim from $90.00 to $100.00. They now have a "buy" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Guggenheim for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€47.20
27.02.24
27.02.24
€82.92
27.02.25
27.02.25
-59.11%
28.02.25
28.02.25
